These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7495982)

  • 1. Rodent models for the study of etiology, prevention and treatment of breast cancer.
    Gould MN
    Semin Cancer Biol; 1995 Jun; 6(3):147-52. PubMed ID: 7495982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse models for the prevention of breast cancer.
    Shen Q; Brown PH
    Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of transforming growth factor beta impact in breast development and cancer.
    Serra R; Crowley MR
    Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
    Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
    Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements.
    Malewicz B; Wang Z; Jiang C; Guo J; Cleary MP; Grande JP; Lü J
    Carcinogenesis; 2006 Sep; 27(9):1739-47. PubMed ID: 16597642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for estrogen and progesterone in breast cancer prevention.
    Jerry DJ
    Breast Cancer Res; 2007; 9(2):102. PubMed ID: 17381827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New rodent models for studies of chemopreventive agents.
    Lipkin M
    J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
    Tsubura A; Uehara N; Matsuoka Y; Yoshizawa K; Yuri T
    In Vivo; 2008; 22(2):191-201. PubMed ID: 18468403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
    Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
    Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats.
    Gould MN
    Semin Cancer Biol; 1993 Jun; 4(3):161-9. PubMed ID: 8318692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models and breast cancer.
    Robinson A
    CMAJ; 1995 Oct; 153(8):1123-4. PubMed ID: 7553521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling.
    Marxfeld H; Staedtler F; Harleman JH
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):133-43. PubMed ID: 16857353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
    Chan T; Sami A; El-Gayed A; Guo X; Xiang J
    Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
    Cardiff RD
    Microsc Res Tech; 2001 Jan; 52(2):224-30. PubMed ID: 11169869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
    Pulaski BA; Ostrand-Rosenberg S
    Cancer Res; 1998 Apr; 58(7):1486-93. PubMed ID: 9537252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.
    Blakely CM; Stoddard AJ; Belka GK; Dugan KD; Notarfrancesco KL; Moody SE; D'Cruz CM; Chodosh LA
    Cancer Res; 2006 Jun; 66(12):6421-31. PubMed ID: 16778221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.